Cepheid weakness a buying opportunity, says Canaccord Canaccord views today's pullback in shares of Cepheid as overdone and reiterates a Buy rating on the stock.
News For CPHD From The Last 14 Days
Check below for free stories on CPHD the last two weeks.
